Asia-Pacific Argatroban Market Analysis 2012-2017 and Forecast 2018-2023
ReportPage
Report ID
25252
Published Date
07-Mar
No of Report Page
107
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details 
    Snapshot
    
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Argatroban Industry
    
        1.1.1 Overview
    
        1.1.2 Development of Argatroban
    
    1.2 Market Segment
    
        1.2.1 By Product Type
    
        1.2.2 By Application
    
    1.3 Asia-Pacific Overview
    
2 Major Companies List
    
    2.1 Pfizer (Company Profile, Products & Services, Sales Data etc.)
    
    2.2 SANDOZ (Company Profile, Products & Services, Sales Data e
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Survey No. 3/1,4/1/3 Rajwade Commercial Complex Office No. 8, Phase 2 Behind SBI Bank, Pune - Bengaluru Hwy, Ambegaon BK, Pune, Maharashtra 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -